ANI Pharmaceuticals
ANIP
ANIP
282 hedge funds and large institutions have $1.67B invested in ANI Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 113 increasing their positions, 77 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $1.87B → $1.67B (-$198M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less call options, than puts
Call options by funds: $11.5M | Put options by funds: $25.2M
Holders
282
Holding in Top 10
1
Calls
$11.5M
Puts
$25.2M
Top Buyers
| 1 | +$41.1M | |
| 2 | +$14.7M | |
| 3 | +$14.2M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$12.6M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$12.6M |
Top Sellers
| 1 | -$48.5M | |
| 2 | -$38M | |
| 3 | -$31.5M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$26.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.1M |
